Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The depot effect is a classical immunological concept describing how certain adjuvants (such as mineral salts—e.g., alum—or oil emulsions like incomplete Freund's adjuvant) enhance the immune response by retaining antigen at the injection site, prolonging antigen exposure and release. This sustained presence recruits and activates innate immune cells, facilitates antigen uptake by APCs, and promotes efficient antigen transport to draining lymph nodes for adaptive immune activation. The depot effect is considered one of several mechanisms by which adjuvants enhance vaccine immunogenicity, alongside direct immune stimulation via pattern-recognition receptors, cytokine induction, and immune polarization. It is not a molecular target but a phenomenon arising from how adjuvant formulations interact with the immune system.
Prolonged antigen retention at the site of injection, local immune cell recruitment and activation, enhancement of antigen uptake by antigen-presenting cells (APCs), induction of cytokine/chemokine production
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Depot effect (adjuvant mechanism).